Results 141 to 150 of about 81,015 (310)

SARS-CoV-2 Infection Is an Independent Risk Factor for Decompensation in Cirrhosis Patients

open access: yesDiseases
Background: SARS-CoV-2 causes varied gastrointestinal symptoms. Cirrhosis patients face higher mortality rates from it, especially those with decompensated cirrhosis.
Mark Ayoub   +5 more
doaj   +1 more source

Characteristics and Clinical Outcomes in Patients With Cirrhosis due to MASLD in Sweden

open access: yesLiver International, Volume 46, Issue 2, February 2026.
ABSTRACT Background and Aims There is limited real‐world data on the prognosis of patients with cirrhosis due to metabolic dysfunction‐associated steatotic liver disease (MASLD). We sought to describe the characteristics and assess the clinical course of MASLD‐cirrhosis.
Ying Shang   +8 more
wiley   +1 more source

Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study

open access: yesLiver International, Volume 46, Issue 2, February 2026.
ABSTRACT Background/Aims Immune checkpoint inhibitors (ICIs) have transformed advanced HCC treatment. The benefit of sequential immunotherapy after prior ICI failure remains unclear. Given the expanded use of atezolizumab plus bevacizumab (Ate/Bev) over the past 5 years, we explored the real‐world outcomes of nivolumab plus ipilimumab (Nivo/Ipi) in ...
Jung Sun Kim   +15 more
wiley   +1 more source

Facts and Misfacts on D‐Dimer Testing. Consensus Guidance From the Italian Society on Thrombosis and Hemostasis (SISET)

open access: yesAmerican Journal of Hematology, Volume 101, Issue 1, Page 97-109, January 2026.
ABSTRACT D‐dimer defines degradation products derived from the proteolysis mediated by plasmin on cross‐linked fibrin. The evidence‐based use of D‐dimer in some conditions has been consolidated. Currently, however, there is an entrenched prescription of D‐dimer testing to screen otherwise healthy subjects that may induce prescribing physicians to start
Armando Tripodi   +11 more
wiley   +1 more source

Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials

open access: yesCancer, Volume 132, Issue 1, 1 January 2026.
Abstract Background Eligibility criteria for clinical trials are crucial for maintaining safety and study integrity. However, overly restrictive criteria can result in unrepresentative trial populations, leading to gaps in understanding real‐world treatment efficacy.
Fen Saj   +12 more
wiley   +1 more source

An Unusual Case of Gastrointestinal Bleeding from Isolated Gallbladder Varices in a Patient with Pancreatic Cancer Complicated by Portal Biliopathy [PDF]

open access: gold, 2016
Mahir Gachabayov   +5 more
openalex   +1 more source

Fetal Tricuspid Annular Plane Systolic Excursion in the Surveillance of Intra‐Abdominal Umbilical Vein Varix

open access: yesJournal of Ultrasound in Medicine, Volume 45, Issue 1, Page 51-58, January 2026.
Objective To describe the application of tricuspid annular plane systolic excursion (TAPSE) in monitoring cardiac function in cases of fetal intra‐abdominal umbilical vein varix (FIUVV). Methods The sample consisted of all cases of FIUVV diagnosed in a tertiary medical center between 2018 and 2023 that were assessed by sonographic fetal TAPSE.
Yossi Geron   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy